The contraceptive efficacy of Implanon®: A review of clinical trials and marketing experience
- 1 January 2008
- journal article
- review article
- Published by Taylor & Francis Ltd in The European Journal of Contraception & Reproductive Health Care
- Vol. 13 (sup1), 4-12
- https://doi.org/10.1080/13625180801942754
Abstract
Objectives To evaluate the contraceptive efficacy of the etonogestrel-releasing implant Implanon® as assessed in international studies and during nine years of marketing experience. Methods The analysis included 11 international studies and data collected during nine years of marketing experience (1998–2007). Seven of these studies were noncomparative; the four other studies included the 6-rod levonorgestrel implant system or an intrauterine device as a comparator. All studies except one were of at least two years in duration, and all had contraceptive efficacy as the objective. Market data were provided unsolicited to Organon, part of Schering-Plough. Results The integrated efficacy analysis included 923 non-breastfeeding women who were exposed to the implant for 24,100 cycles. No in-treatment or pretreatment pregnancies were reported. Fifty posttreatment pregnancies were reported, six of which occurred within 14 days of implant removal, indicating that fertility had quickly returned. Over a nine-year marketing period an overall pregnancy rate of 0.049 per 100 implants sold (estimated Pearl Index = 0.031 based on all pregnancies reported) was calculated. When only counting contraceptive method failures the pregnancy rate amounts to 0.010 per 100 implants sold (estimated Pearl Index = 0.006). Conclusion Implanon® is a highly effective and quickly reversible subdermal method of long-acting hormonal contraception for women. Typical use of this implant achieves a contraceptive protection exceeding 99%.Keywords
This publication has 7 references indexed in Scilit:
- Continuation rates of Implanon® in the UK: data from an observational study in a clinical settingContraception, 2006
- An assessment of the first 3 years' use of Implanon(R) in LutonBMJ Sexual & Reproductive Health, 2005
- Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in AustraliaContraception, 2005
- Experience with Implanon in a northeast London family planning clinic.The European Journal of Contraception & Reproductive Health Care, 2004
- Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon®Contraception, 1998
- Ovarian Function During the Use of a Single Contraceptive Implant: Implanon Compared with NorplantFertility and Sterility, 1998
- Release characteristics, ovarian activity and menstrual bleeding pattern with a single contraceptive implant releasing 3-ketodesogestrelContraception, 1993